Weidong Hong

Title: Weidong Hong: Innovator in Medical Biotechnology

Introduction

Weidong Hong is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical biotechnology, particularly through his innovative research and development of therapeutic proteins.

Latest Patents

Weidong Hong holds a patent for an "Anti-IL-17 antibody/TNFR ECD fusion protein and use thereof." This invention relates to a fusion protein that combines an anti-interleukin-17 antibody with a tumor necrosis factor receptor extracellular region. The patent encompasses a polynucleotide encoding the fusion protein, a vector containing the polynucleotide, and a host cell that includes the polynucleotide or vector. The fusion protein is intended for the treatment, prevention, and diagnosis of related diseases in individuals. He has 1 patent to his name.

Career Highlights

Throughout his career, Weidong Hong has worked with notable companies in the biotechnology sector. He has been associated with Beijing Beyond Biotechnology Co., Ltd and Hangzhou Polymed Biopharmaceuticals, Inc. His work in these organizations has contributed to advancements in biopharmaceuticals and therapeutic solutions.

Collaborations

Weidong Hong has collaborated with several professionals in his field, including Pinliang Hu and Jing Zou. These collaborations have fostered innovation and development in medical biotechnology.

Conclusion

Weidong Hong's contributions to medical biotechnology through his patent and career achievements highlight his role as an influential inventor. His work continues to impact the field positively, paving the way for future advancements in therapeutic treatments.